Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors

Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factorsImmediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors, Published online: 14 November 2018; doi:10.1038/s41391-018-0109-yImmediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors

Source: Prostate Cancer and Prostatic Diseases - November 14, 2018 Category: Urology & Nephrology Authors: Hanneke Jansen Inge M. van Oort George van Andel Bart P. Wijsman Floris J. Pos Maarten C. C. M. Hulshof Christina A. Hulsbergen-van de Kaa Geert J. L. H. van Leenders Jurgen.J. F ütterer Diederink M. Somford Martijn B. Busstra Reindert J. A. van Moorsela Source Type: research